The Canton of Vaud’s University Hospital (CHUV) plays a central role in medical treatments, research and education. It develops ambitious projects such as Neurotech, a platform unique in Europe that is dedicated to assessing the impact of connected medical devices. The Department of Oncology conducts internationally renowned work, in particular in the field of immunotherapy.
The region positions itself at the forefront of research in these fields, as well as in those of neuroscience, immunology, nutrition and cardiovascular illnesses. Innovative disciplines such as bioinformatics, medical imaging and robotic surgery are also developing fast. There are close to 400 companies in the Canton and the same number of laboratories active in life sciences, representing a total of more than 20,000 jobs.
“The European Society of Gene and Cell Therapy was very happy to organise their annual congress in Lausanne. The city was chosen first for the strength of its local organising committee, which included renowned researchers in the field of gene and cell therapy. We were easily convinced that Lausanne would be the perfect city for us to organise this event mainly thanks to the state-of-the-art venue, which was without a doubt one of the best spaces we have ever had in many years of congress organising. Our delegates agreed, and scored the venue very highly in their event feedback. The size of the city and quality of the hotels, as well as the choice of excellent spaces for evening activities, were also important incentives in our choice. The congress went extremely well and definitely met ourselves’ and our delegates’ expectations.”
Gaëlle Jamar, Events Manager, ESCT – European Society of Gene and Cell Therapy